Cancer Staging Code Definition: International Standardization based on SNOMED CT and FHIR
ValueSet: SCT + NCI-ๅฅไฟไบๅๅฏฉๆฅ-็็ๅๆ้่กจ้ ็ฎๅผ้
Summary
A Taiwanese health information organization has published a ValueSet for cancer staging. This set is based on HL7 FHIR R4, aggregating codes from multiple standards like SNOMED CT, covering numerous international cancer staging systems (e.g., Gleason score, FIGO stage).
Details
This page defines the ValueSet titled 'SCT + NCI-ๅฅไฟไบๅๅฏฉๆฅ-็็ๅๆ้่กจ้ ็ฎๅค้'. It is part of Taiwan's medical information guidelines (TWPAS IG v1.2.2) and is explicitly based on the HL7 FHIR R4 standard. This ValueSet comprehensively defines codes from diverse international and regional cancer staging systems (e.g., Gleason grade finding for prostatic cancer, FIGO stage for gynaecological malignancy). Specifically, it incorporates standardized terminology related to various diseases and conditions from SNOMED CT, centralizing multiple staging systems (TNM stage grouping, Ann Arbor lymphoma staging system, etc.). This effort is crucial for enhancing global healthcare data interoperability by enabling the unified handling of diverse cancer diagnostic criteria used across different medical institutions and regions under the international standard FHIR. The definition includes not only SNOMED CT codes but also Taiwan's unique classification systems (e.g., Myeloma ISS Stage).
Original content copyright by respective publishers